nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—NFATC1—periosteum—bone cancer	0.0923	0.527	CbGeAlD
Pseudoephedrine—NFATC1—connective tissue—bone cancer	0.0161	0.0918	CbGeAlD
Pseudoephedrine—IL2—connective tissue—bone cancer	0.0147	0.084	CbGeAlD
Pseudoephedrine—NFATC1—tendon—bone cancer	0.0111	0.0631	CbGeAlD
Pseudoephedrine—NFATC1—bone marrow—bone cancer	0.0107	0.0611	CbGeAlD
Pseudoephedrine—IL2—bone marrow—bone cancer	0.0098	0.0559	CbGeAlD
Pseudoephedrine—ADRB1—connective tissue—bone cancer	0.00369	0.021	CbGeAlD
Pseudoephedrine—MAOA—connective tissue—bone cancer	0.00289	0.0165	CbGeAlD
Pseudoephedrine—SLC6A3—spinal cord—bone cancer	0.00258	0.0147	CbGeAlD
Pseudoephedrine—SLC6A4—spinal cord—bone cancer	0.00236	0.0135	CbGeAlD
Pseudoephedrine—ADRA2A—connective tissue—bone cancer	0.00222	0.0127	CbGeAlD
Pseudoephedrine—MAOA—tendon—bone cancer	0.00199	0.0113	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—bone cancer	0.00192	0.0109	CbGeAlD
Pseudoephedrine—ADRA2A—tendon—bone cancer	0.00152	0.0087	CbGeAlD
Pseudoephedrine—ADRA2A—spinal cord—bone cancer	0.00147	0.00839	CbGeAlD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—JUN—bone cancer	0.000852	0.00103	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000852	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GRM1—bone cancer	0.000851	0.00103	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—IL3—bone cancer	0.000841	0.00102	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—GRM4—bone cancer	0.000822	0.000998	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—CDK4—bone cancer	0.00082	0.000995	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNA11—bone cancer	0.000814	0.000988	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—SPARC—bone cancer	0.000809	0.000982	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ATF1—bone cancer	0.000788	0.000957	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—JUN—bone cancer	0.000785	0.000953	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—PTGS2—bone cancer	0.000775	0.00094	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—IL3—bone cancer	0.000769	0.000933	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—GRM4—bone cancer	0.000764	0.000927	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—TUBB2A—bone cancer	0.000755	0.000916	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—GNA11—bone cancer	0.00074	0.000898	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000737	0.000895	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NDUFA12—bone cancer	0.000736	0.000893	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—bone cancer	0.000734	0.000891	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—BRAF—bone cancer	0.000723	0.000878	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TGFBR2—bone cancer	0.000718	0.000871	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—MDM2—bone cancer	0.000717	0.000871	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—GRM1—bone cancer	0.000713	0.000865	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SMO—bone cancer	0.000709	0.00086	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MMP9—bone cancer	0.00068	0.000825	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IL3—bone cancer	0.000671	0.000815	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—GRM1—bone cancer	0.000662	0.000804	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—GNA11—bone cancer	0.000648	0.000787	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—JUN—bone cancer	0.000647	0.000785	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—bone cancer	0.000636	0.000772	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—JUN—bone cancer	0.000624	0.000757	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—SMO—bone cancer	0.00062	0.000753	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—JUN—bone cancer	0.000613	0.000744	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—NT5C3A—bone cancer	0.00061	0.00074	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—SMO—bone cancer	0.000607	0.000737	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—bone cancer	0.000605	0.000735	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ATF1—bone cancer	0.000603	0.000732	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SMO—bone cancer	0.000599	0.000728	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	0.000597	0.000724	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IL3—bone cancer	0.000588	0.000713	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GRM4—bone cancer	0.000574	0.000697	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—RGS1—bone cancer	0.000574	0.000697	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GRM4—bone cancer	0.000562	0.000682	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—RGS1—bone cancer	0.000562	0.000682	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—JUN—bone cancer	0.000559	0.000678	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—BRAF—bone cancer	0.000555	0.000673	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—bone cancer	0.000549	0.000667	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GNA11—bone cancer	0.000548	0.000666	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000547	0.000664	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—CYP3A4—bone cancer	0.000534	0.000649	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—KIT—bone cancer	0.00053	0.000644	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	0.00053	0.000644	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—JUN—bone cancer	0.000528	0.000641	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000527	0.00064	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—CYP3A4—bone cancer	0.000527	0.00064	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—JUN—bone cancer	0.000527	0.000639	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GRM4—bone cancer	0.000521	0.000633	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—RGS1—bone cancer	0.000521	0.000633	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GRM4—bone cancer	0.00051	0.000619	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—RGS1—bone cancer	0.00051	0.000619	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ATF1—bone cancer	0.00051	0.000619	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TGFBR2—bone cancer	0.000503	0.00061	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—SMO—bone cancer	0.000502	0.000609	CbGpPWpGaD
Pseudoephedrine—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	0.0005	0.000607	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GRM1—bone cancer	0.000498	0.000604	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IL3—bone cancer	0.000497	0.000603	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NDUFA12—bone cancer	0.000492	0.000597	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—bone cancer	0.00049	0.000595	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—KIT—bone cancer	0.00049	0.000595	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GRM1—bone cancer	0.000487	0.000591	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—bone cancer	0.000483	0.000587	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000475	0.000577	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IGF1R—bone cancer	0.000473	0.000574	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—SMO—bone cancer	0.000466	0.000566	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmission across Chemical Synapses—MDM2—bone cancer	0.000465	0.000564	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GRM4—bone cancer	0.000464	0.000564	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—RGS1—bone cancer	0.000464	0.000564	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—bone cancer	0.000461	0.00056	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—BRAF—bone cancer	0.00046	0.000559	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—BRAF—bone cancer	0.000457	0.000555	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—GSTP1—bone cancer	0.000457	0.000555	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GRM1—bone cancer	0.000452	0.000549	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—GSTP1—bone cancer	0.000451	0.000547	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—KIT—bone cancer	0.000449	0.000545	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GRM1—bone cancer	0.000442	0.000537	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—RGS1—bone cancer	0.000432	0.000524	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GRM4—bone cancer	0.000432	0.000524	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TGFBR2—bone cancer	0.000425	0.000516	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—BRAF—bone cancer	0.000425	0.000516	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GRM4—bone cancer	0.000422	0.000512	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—RGS1—bone cancer	0.000422	0.000512	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MDM2—bone cancer	0.000418	0.000507	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SPARC—bone cancer	0.000417	0.000506	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—bone cancer	0.000414	0.000502	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—NT5C3A—bone cancer	0.000407	0.000494	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GRM1—bone cancer	0.000403	0.000489	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IGF1R—bone cancer	0.0004	0.000486	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—RGS1—bone cancer	0.000392	0.000476	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GRM4—bone cancer	0.000392	0.000476	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—bone cancer	0.000387	0.000469	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MDM2—bone cancer	0.000386	0.000468	CbGpPWpGaD
Pseudoephedrine—MAOA—Neuronal System—MDM2—bone cancer	0.000383	0.000465	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GNA11—bone cancer	0.000382	0.000463	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GRM1—bone cancer	0.000374	0.000454	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000374	0.000453	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—bone cancer	0.000372	0.000451	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—bone cancer	0.000371	0.00045	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GRM1—bone cancer	0.000366	0.000444	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—JUN—bone cancer	0.000363	0.000441	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Neuronal System—MDM2—bone cancer	0.000356	0.000432	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MDM2—bone cancer	0.000353	0.000429	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—bone cancer	0.000349	0.000423	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—bone cancer	0.000348	0.000422	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IL3—bone cancer	0.000346	0.00042	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CDK4—bone cancer	0.000345	0.000419	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MET—bone cancer	0.000345	0.000419	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—KIT—bone cancer	0.000343	0.000416	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GRM1—bone cancer	0.00034	0.000412	CbGpPWpGaD
Pseudoephedrine—Benzyl alcohol—CYP3A4—bone cancer	0.000326	0.372	CrCbGaD
Pseudoephedrine—NFATC1—Signaling Pathways—BRAF—bone cancer	0.000322	0.000391	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—GNA11—bone cancer	0.000321	0.000389	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NDUFA12—bone cancer	0.00032	0.000389	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—SMO—bone cancer	0.000318	0.000387	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—GNA11—bone cancer	0.000314	0.000381	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000314	0.000381	CbGpPWpGaD
Pseudoephedrine—Selegiline—CYP3A4—bone cancer	0.000313	0.357	CrCbGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—SMO—bone cancer	0.000311	0.000378	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RGS1—bone cancer	0.000308	0.000374	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GRM4—bone cancer	0.000308	0.000374	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—JUN—bone cancer	0.000307	0.000373	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GRM4—bone cancer	0.000301	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RGS1—bone cancer	0.000301	0.000366	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—GNA11—bone cancer	0.000291	0.000354	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—IL3—bone cancer	0.000291	0.000353	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—KIT—bone cancer	0.00029	0.000352	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP2—bone cancer	0.000288	0.000349	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—bone cancer	0.000286	0.000347	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—GNA11—bone cancer	0.000285	0.000346	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—IL3—bone cancer	0.000284	0.000345	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—BRAF—bone cancer	0.000273	0.000331	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MDM2—bone cancer	0.00027	0.000328	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—ENO2—bone cancer	0.000267	0.000324	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GRM1—bone cancer	0.000267	0.000324	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—NT5C3A—bone cancer	0.000265	0.000322	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—bone cancer	0.000264	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—IL3—bone cancer	0.000264	0.00032	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—bone cancer	0.000264	0.00032	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GRM1—bone cancer	0.000261	0.000317	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	0.000259	0.000315	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—IL3—bone cancer	0.000258	0.000314	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—SMO—bone cancer	0.000258	0.000313	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GRM4—bone cancer	0.000249	0.000302	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RGS1—bone cancer	0.000249	0.000302	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—DHFR—bone cancer	0.000248	0.000301	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—bone cancer	0.000241	0.000293	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	0.000241	0.000293	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—SMO—bone cancer	0.000239	0.000291	CbGpPWpGaD
Pseudoephedrine—Atomoxetine—CYP3A4—bone cancer	0.000237	0.271	CrCbGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	0.000236	0.000286	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	0.000235	0.000286	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—JUN—bone cancer	0.000235	0.000285	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000232	0.000281	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GNA11—bone cancer	0.000232	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GRM4—bone cancer	0.000231	0.000281	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RGS1—bone cancer	0.000231	0.000281	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MDM2—bone cancer	0.000228	0.000277	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—bone cancer	0.000228	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLAU—bone cancer	0.000227	0.000275	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	0.000219	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	0.000219	0.000265	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—bone cancer	0.000216	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GRM1—bone cancer	0.000216	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—IL3—bone cancer	0.000214	0.000259	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CYP3A4—bone cancer	0.00021	0.000255	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GRM1—bone cancer	0.000201	0.000244	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—JUN—bone cancer	0.000199	0.000241	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—IL3—bone cancer	0.000198	0.000241	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—bone cancer	0.000193	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SMO—bone cancer	0.000188	0.000228	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—bone cancer	0.000185	0.000224	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SMO—bone cancer	0.000184	0.000223	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTP1—bone cancer	0.00018	0.000218	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—ENO2—bone cancer	0.000178	0.000217	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—bone cancer	0.000175	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GNA11—bone cancer	0.000172	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GNA11—bone cancer	0.000168	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—DHFR—bone cancer	0.000166	0.000201	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ATF1—bone cancer	0.00016	0.000194	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ATF1—bone cancer	0.000156	0.00019	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—bone cancer	0.000156	0.00019	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IL3—bone cancer	0.000156	0.000189	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—bone cancer	0.000155	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GNA11—bone cancer	0.000155	0.000188	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IL3—bone cancer	0.000153	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SMO—bone cancer	0.000152	0.000185	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SMO—bone cancer	0.000141	0.000172	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CYP3A4—bone cancer	0.00014	0.00017	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GNA11—bone cancer	0.000139	0.000169	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TGFBR2—bone cancer	0.000133	0.000162	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—bone cancer	0.000131	0.000159	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TGFBR2—bone cancer	0.00013	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ATF1—bone cancer	0.000129	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GNA11—bone cancer	0.000129	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IL3—bone cancer	0.000126	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1R—bone cancer	0.000126	0.000152	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1R—bone cancer	0.000123	0.000149	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATF1—bone cancer	0.00012	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTP1—bone cancer	0.00012	0.000146	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IL3—bone cancer	0.000117	0.000142	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—ENO2—bone cancer	0.000116	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	0.000108	0.000131	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—DHFR—bone cancer	0.000108	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	0.000102	0.000123	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GNA11—bone cancer	0.000101	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	0.0001	0.000122	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	9.44e-05	0.000115	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—bone cancer	9.3e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CYP3A4—bone cancer	9.14e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—bone cancer	9.12e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—KIT—bone cancer	9.1e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—KIT—bone cancer	8.9e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—BRAF—bone cancer	8.56e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—BRAF—bone cancer	8.37e-05	0.000102	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—bone cancer	8.29e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—bone cancer	8.11e-05	9.85e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—bone cancer	7.82e-05	9.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—KIT—bone cancer	7.37e-05	8.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MDM2—bone cancer	7.17e-05	8.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MDM2—bone cancer	7.01e-05	8.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—BRAF—bone cancer	6.92e-05	8.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—KIT—bone cancer	6.84e-05	8.31e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	6.71e-05	8.15e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—BRAF—bone cancer	6.43e-05	7.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	6.23e-05	7.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—JUN—bone cancer	6.23e-05	7.56e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—bone cancer	6.21e-05	7.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—JUN—bone cancer	6.1e-05	7.4e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—bone cancer	6.06e-05	7.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—bone cancer	5.93e-05	7.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MDM2—bone cancer	5.8e-05	7.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MDM2—bone cancer	5.39e-05	6.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—JUN—bone cancer	5.04e-05	6.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—bone cancer	4.91e-05	5.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—bone cancer	4.9e-05	5.95e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—bone cancer	4.79e-05	5.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—JUN—bone cancer	4.68e-05	5.69e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—bone cancer	4.56e-05	5.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—bone cancer	4.11e-05	4.99e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—bone cancer	4.05e-05	4.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—bone cancer	4.02e-05	4.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—bone cancer	3.96e-05	4.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—bone cancer	3.68e-05	4.47e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—bone cancer	3.33e-05	4.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—bone cancer	3.09e-05	3.75e-05	CbGpPWpGaD
